Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eugene Bichenkov"'
Autor:
Noreen McBrearty, Alla Arzumanyan, Eugene Bichenkov, Salim Merali, Carmen Merali, Mark Feitelson
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 5, Pp 529-538 (2021)
Chronic infection with hepatitis B virus (HBV) is a major risk factor for the development of hepatocellular carcinoma (HCC). The HBV encoded oncoprotein, HBx, alters the expression of host genes and the activity of multiple signal transduction pathwa
Externí odkaz:
https://doaj.org/article/57637a8580564887a2fbb70606014cd3
Autor:
Selwyn J. Hurwitz, Noreen McBrearty, Alla Arzumanyan, Eugene Bichenkov, Sijia Tao, Leda Bassit, Zhe Chen, James J. Kohler, Franck Amblard, Mark A. Feitelson, Raymond F. Schinazi
Publikováno v:
Viruses, Vol 13, Iss 1, p 114 (2021)
While treatment options are available for hepatitis B virus (HBV), there is currently no cure. Anti-HBV nucleoside analogs and interferon-alpha 2b rarely clear HBV covalently closed circular DNA (cccDNA), requiring lifelong treatment. Recently, we id
Externí odkaz:
https://doaj.org/article/74d257cd15f04e9c84764a13e9c822eb
Autor:
Salim Merali, Mark A. Feitelson, Alla Arzumanyan, Eugene Bichenkov, Noreen McBrearty, Carmen Merali
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 5, Pp 529-538 (2021)
Neoplasia (New York, N.Y.)
Neoplasia (New York, N.Y.)
Chronic infection with hepatitis B virus (HBV) is a major risk factor for the development of hepatocellular carcinoma (HCC). The HBV encoded oncoprotein, HBx, alters the expression of host genes and the activity of multiple signal transduction pathwa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2156c503eb0ed831aca826d3f28ccb93
http://www.sciencedirect.com/science/article/pii/S1476558621000245
http://www.sciencedirect.com/science/article/pii/S1476558621000245
Autor:
Alla Arzumanyan, Zhe Chen, Noreen McBrearty, James J. Kohler, Leda Bassit, Mark A. Feitelson, Sijia Tao, Eugene Bichenkov, Selwyn J. Hurwitz, Raymond F. Schinazi, Franck Amblard
Publikováno v:
Viruses, Vol 13, Iss 114, p 114 (2021)
Viruses
Volume 13
Issue 1
Viruses
Volume 13
Issue 1
While treatment options are available for hepatitis B virus (HBV), there is currently no cure. Anti-HBV nucleoside analogs and interferon-alpha 2b rarely clear HBV covalently closed circular DNA (cccDNA), requiring lifelong treatment. Recently, we id
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1fe31de815bf79e2c6f760a89259c3b
https://doi.org/10.3390/v13010114
https://doi.org/10.3390/v13010114